Baystate Wealth Management LLC Abbott Laboratories Transaction History

Baystate Wealth Management LLC

$1.36 Billion
Q4 2023

A detailed history of Baystate Wealth Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Baystate Wealth Management LLC holds 5,661 shares of ABT stock, worth $663,808. This represents 0.05% of its overall portfolio holdings.

Number of Shares

5,661

Previous 5,640 0.37%

Holding current value

$663,808

Previous $546,000 14.1%

% of portfolio

0.05%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	BUY	$90.19 - $110.4 $1,893 - $2,318	21 Added 0.37%	5,661 $623,000
Q3 2023 Oct 25, 2023	SELL	$95.53 - $114.62 $10,317 - $12,378	-108 Reduced 1.88%	5,640 $546,000
Q2 2023 Sep 21, 2023	SELL	$100.78 - $112.29 $324,511 - $361,573	-3,220 Reduced 35.91%	5,748 $626,000
Q2 2023 Aug 02, 2023	BUY	$100.78 - $112.29 $354,846 - $395,373	3,521 Added 64.64%	8,968 $977,000
Q1 2023 Apr 25, 2023	BUY	$96.86 - $114.01 $2,227 - $2,622	23 Added 0.42%	5,447 $551,000
Q4 2022 Jan 12, 2023	BUY	$95.06 - $111.52 $1,425 - $1,672	15 Added 0.28%	5,424 $596,000
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $1,451 - $1,680	15 Added 0.28%	5,409 $523,000
Q2 2022 Aug 02, 2022	SELL	$102.07 - $123.37 $13,983 - $16,901	-137 Reduced 2.48%	5,394 $586,000
Q1 2022 Apr 19, 2022	BUY	$114.02 - $139.04 $1,368 - $1,668	12 Added 0.22%	5,531 $655,000
Q4 2021 Jan 21, 2022	BUY	$115.53 - $141.46 $22,066 - $27,018	191 Added 3.58%	5,519 $777,000
Q3 2021 Nov 05, 2021	BUY	$116.66 - $129.06 $29,631 - $32,781	254 Added 5.01%	5,328 $629,000
Q2 2021 Jul 26, 2021	SELL	$105.79 - $124.53 $15,551 - $18,305	-147 Reduced 2.82%	5,074 $588,000
Q1 2021 Apr 21, 2021	SELL	$108.84 - $128.23 $8,271 - $9,745	-76 Reduced 1.43%	5,221 $626,000
Q4 2020 Jan 15, 2021	SELL	$105.0 - $114.42 $126,105 - $137,418	-1,201 Reduced 18.48%	5,297 $580,000
Q3 2020 Oct 14, 2020	BUY	$91.64 - $111.29 $19,336 - $23,482	211 Added 3.36%	6,498 $707,000
Q2 2020 Jul 28, 2020	BUY	$76.57 - $98.0 $67,075 - $85,848	876 Added 16.19%	6,287 $575,000
Q1 2020 Apr 22, 2020	BUY	$62.82 - $91.86 $5,528 - $8,083	88 Added 1.65%	5,411 $427,000
Q4 2019 Jan 21, 2020	BUY	$78.51 - $87.4 $62,336 - $69,395	794 Added 17.53%	5,323 $462,000
Q3 2019 Oct 30, 2019	BUY	$81.84 - $88.74 $13,258 - $14,375	162 Added 3.71%	4,529 $379,000
Q2 2019 Jul 02, 2019	SELL	$72.88 - $85.0 $43,072 - $50,235	-591 Reduced 11.92%	4,367 $369,000
Q1 2019 Apr 25, 2019	BUY	$66.22 - $80.06 $7,615 - $9,206	115 Added 2.37%	4,958 $381,000
Q4 2018 Jan 24, 2019	BUY	$65.56 - $74.27 $19,864 - $22,503	303 Added 6.67%	4,843 $346,000
Q3 2018 Oct 16, 2018	BUY	$60.81 - $73.36 $1,033 - $1,247	17 Added 0.38%	4,540 $313,000
Q2 2018 Jul 17, 2018	BUY	$57.57 - $63.54 $9,729 - $10,738	169 Added 3.88%	4,523 $283,000
Q1 2018 Apr 24, 2018	BUY	$56.27 - $63.62 $562 - $636	10 Added 0.23%	4,354 $256,000
Q4 2017 Jan 23, 2018	SELL	$53.68 - $57.47 $23,189 - $24,827	-432 Reduced 9.05%	4,344 $259,000
Q3 2017 Oct 10, 2017	BUY	$48.06 - $53.64 $229,534 - $256,184	4,776	4,776 $261,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baystate Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baystate Wealth Management LLC with notifications on news.

Account

Baystate Wealth Management LLC Abbott Laboratories Transaction History